CCR6 Is a Prognostic Marker for Overall Survival in Patients with Colorectal Cancer, and Its Overexpression Enhances Metastasis In Vivo | PLOS ONE
Cancers | Free Full-Text | Targeting Microtubule-Associated Protein Tau in Chemotherapy-Resistant Models of High-Grade Serous Ovarian Carcinoma
Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma - Chen - 2020 - Cancer Medicine - Wiley Online Library
IHC PANEL MARKERS
Effect of Ion Transporters in Brain Tumor Stem Cell Migration - Brain Tumor Stem Cell Research Lab - Mayo Clinic Research
McGill University Health Centre
Histone proteomics reveals novel post-translational modifications in breast cancer | Aging
Cancers | Free Full-Text | Cancer Cells Upregulate Tau to Gain Resistance to DNA Damaging Agents
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression | Nature Communications
Macroscopic fluorescence-lifetime imaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors | Scientific Reports
JCI - Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts
Salivary Glycopatterns as Potential Biomarkers for Screening of Early-Stage Breast Cancer - eBioMedicine
Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin - ScienceDirect
Cancers | Free Full-Text | Bromamine T (BAT) Exerts Stronger Anti-Cancer Properties than Taurine (Tau)
TAU-20-1124_Peer Review File
Liquid biopsies and cancer omics | Cell Death Discovery
Cancers | Free Full-Text | Targeting Microtubule-Associated Protein Tau in Chemotherapy-Resistant Models of High-Grade Serous Ovarian Carcinoma
Cancers | Free Full-Text | Targeting Microtubule-Associated Protein Tau in Chemotherapy-Resistant Models of High-Grade Serous Ovarian Carcinoma
Cancers | Free Full-Text | Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
Frontiers | Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
Loss of dyskerin facilitates the acquisition of metastatic traits by altering the mevalonate pathway | Life Science Alliance
Cancers | Free Full-Text | Targeting Microtubule-Associated Protein Tau in Chemotherapy-Resistant Models of High-Grade Serous Ovarian Carcinoma
Polyaniline@Au organic-inorganic nanohybrids with thermometer readout for photothermal immunoassay of tumor marker | SpringerLink
Clinical and Experimental Pediatrics
Cancers | Free Full-Text | Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
